|
1
|
Burdon T, Smith A and Savatier P:
Signalling, cell cycle and pluripotency in embryonic stem cells.
Trends Cell Biol. 12:432–438. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Rosner MH, Vigano MA, Ozato K, Timmons PM,
Poirier F, Rigby PW and Staudt LM: A POU-domain transcription
factor in early stem cells and germ cells of the mammalian embryo.
Nature. 345:686–692. 1990. View
Article : Google Scholar : PubMed/NCBI
|
|
3
|
Nichols J, Zevnik B, Anastassiadis K, Niwa
H, Klewe-Nebenius D, Chambers I, Schöler H and Smith A: Formation
of pluripotent stem cells in the mammalian embryo depends on the
POU transcription factor Oct4. Cell. 95:379–391. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Pesce M and Schöler HR: Oct-4: Gatekeeper
in the beginnings of mammalian development. Stem Cells. 19:271–278.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Scholer HR: Octamania: The POU factors in
murine development. Trends Genet. 7:323–329. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kraft HJ, Mosselman S, Smits HA,
Hohenstein P, Piek E, Chen Q, Artzt K and van Zoelen EJ: Oct-4
regulates alternative platelet-derived growth factor alpha receptor
gene promoter in human embryonal carcinoma cells. J Biol Chem.
271:12873–12878. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lamb KA and Rizzino A: Effects of
differentiation on the transcriptional regulation of the FGF-4
gene: Critical roles played by a distal enhancer. Mol Reprod Dev.
51:218–224. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Chen Z, Xu WR, Qian H, Zhu W, Bu XF, Wang
S, Yan YM, Mao F, Gu HB, Cao HL, et al: Oct4, a novel marker for
human gastric cancer. J Surg Oncol. 99:414–419. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhang Y, Zhang X, Wang X, Gan L, Yu G,
Chen Y, Liu K, Li P, Pan J, Wang J, et al: Inhibition of LDH-A by
lentivirus-mediated small interfering RNA suppresses
intestinal-type gastric cancer tumorigenicity through the
downregulation of Oct4. Cancer Lett. 321:45–54. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kim RJ and Nam JS: OCT4 expression
enhances features of cancer stem cells in a mouse model of breast
cancer. Lab Anim Res. 27:147–152. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Iida H, Suzuki M, Goitsuka R and Ueno H:
Hypoxia induces CD133 expression in human lung cancer cells by
up-regulation of OCT3/4 and SOX2. Int J Oncol. 40:71–79.
2012.PubMed/NCBI
|
|
12
|
Fang XF, Zhang WY, Zhao N, Yu W, Ding D,
Hong X, Li LS, Zhang HR, Zheng S and Lin BY: Genome-wide analysis
of OCT4 binding sites in glioblastoma cancer cells. J Zhejiang Univ
Sci B. 12:812–819. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Guo Y, Liu S, Wang P, Zhao S, Wang F, Bing
L, Zhang Y, Ling EA, Gao J and Hao A: Expression profile of
embryonic stem cell-associated genes Oct4, Sox2 and Nanog in human
gliomas. Histopathology. 59:763–775. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ikushima H, Todo T, Ino Y, Takahashi M,
Saito N, Miyazawa K and Miyazono K: Glioma-initiating cells retain
their tumorigenicity through integration of the Sox axis and Oct4
protein. J Biol Chem. 286:41434–41441. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
He W, Li K, Wang F, Qin YR and Fan QX:
Expression of OCT4 in human esophageal squamous cell carcinoma is
significantly associated with poorer prognosis. World J
Gastroenterol. 18:712–719. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Cheng L, Sung MT, Cossu-Rocca P, Jones TD,
MacLennan GT, De Jong J, Lopez-Beltran A, Montironi R and Looijenga
LH: OCT4: Biological functions and clinical applications as a
marker of germ cell neoplasia. J Pathol. 211:1–9. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Jones TD, Ulbright TM, Eble JN and Cheng
L: OCT4: A sensitive and specific biomarker for intratubular germ
cell neoplasia of the testis. Clin Cancer Res. 10:8544–8547. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Chen YC, Hsu HS, Chen YW, Tsai TH, How CK,
Wang CY, Hung SC, Chang YL, Tsai ML, Lee YY, et al: Oct-4
expression maintained cancer stem-like properties in lung
cancer-derived CD133-positive cells. PLoS One. 3:e26372008.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2012. CA Cancer J Clin. 62:10–29. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Alison MR, Islam S and Wright NA: Stem
cells in cancer: Instigators and propagators? J Cell Sci.
123:2357–2368. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Li Y and Laterra J: Cancer stem cells:
Distinct entities or dynamically regulated phenotypes? Cancer Res.
72:576–580. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
O'Brien CA, Pollett A, Gallinger S and
Dick JE: A human colon cancer cell capable of initiating tumour
growth in immunodeficient mice. Nature. 445:106–110. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ricci-Vitiani L, Lombardi DG, Pilozzi E,
Biffoni M, Todaro M, Peschle C and De Maria R: Identification and
expansion of human colon-cancer-initiating cells. Nature.
445:111–115. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wu WK, Law PT, Lee CW, Cho CH, Fan D, Wu
K, Yu J and Sung JJ: MicroRNA in colorectal cancer: From benchtop
to bedside. Carcinogenesis. 32:247–253. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Compton CC: Colorectal carcinoma:
Diagnostic, prognostic and molecular features. Mod Pathol.
16:376–388. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
You WC, Jin F, Devesa S, Gridley G,
Schatzkin A, Yang G, Rosenberg P, Xiang YB, Hu YR and Li Q: Rapid
increase in colorectal cancer rates in urban Shanghai, 1972–97, in
relation to dietary changes. J Cancer Epidemiol Prev. 7:143–146.
2002.PubMed/NCBI
|
|
27
|
Dalerba P, Dylla SJ, Park IK, Liu R, Wang
X, Cho RW, Hoey T, Gurney A, Huang EH, Simeone DM, et al:
Phenotypic characterization of human colorectal cancer stem cells.
Proc Natl Acad Sci USA. 104:10158–10163. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Shmelkov SV, Butler JM, Hooper AT, Hormigo
A, Kushner J, Milde T, St Clair R, Baljevic M, White I, Jin DK, et
al: CD133 expression is not restricted to stem cells and both
CD133+ and CD133-metastatic colon cancer cells initiate tumors. J
Clin Invest. 118:2111–2120. 2008.PubMed/NCBI
|
|
29
|
Hochedlinger K, Yamada Y, Beard C and
Jaenisch R: Ectopic expression of Oct-4 blocks progenitor-cell
differentiation and causes dysplasia in epithelial tissues. Cell.
121:465–477. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Dai X, Ge J, Wang X, Qian X, Zhang C and
Li X: OCT4 regulates epithelial-mesenchymal transition and its
knockdown inhibits colorectal cancer cell migration and invasion.
Oncol Rep. 29:155–160. 2013.PubMed/NCBI
|
|
31
|
Wang Q, He W, Lu C, Wang Z, Wang J,
Giercksky KE, Nesland JM and Suo Z: Oct3/4 and Sox2 are
significantly associated with an unfavorable clinical outcome in
human esophageal squamous cell carcinoma. Anticancer Res.
29:1233–1241. 2009.PubMed/NCBI
|
|
32
|
Cortes-Dericks L, Galetta D, Spaggiari L,
Schmid RA and Karoubi G: High expression of octamer-binding
transcription factor 4A, prominin-1 and aldehyde dehydrogenase
strongly indicates involvement in the initiation of lung
adenocarcinoma resulting in shorter disease-free intervals. Eur J
Cardiothorac Surg. 41:e173–e181. 2012. View Article : Google Scholar : PubMed/NCBI
|
